NCT06790641 Pathways to Perinatal Mental Health Equity
| NCT ID | NCT06790641 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Perinatal Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,270 participants |
| Start Date | 2025-12-05 |
| Primary Completion | 2030-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,270 participants in total. It began in 2025-12-05 with a primary completion date of 2030-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mental health conditions occurring during pregnancy and up to one year postpartum (the perinatal period) occur in 1 in 5 perinatal individuals. To improve mental health care during the perinatal period, this study will implement and compare a health care model of improving mood and anxiety disorder care in practices with a health care-community partnership model. The study will include 32 perinatal care settings across the United States. Half of them will have the health care model, the other half will have the health care-community partnership model. The study is designed to answer the question, "Should states and healthcare systems put resources into a healthcare system approach or a healthcare-community partnership approach to mental health care?" The results of this study will help states and healthcare systems decide how to develop pathways for increasing access to mental health care for pregnant and postpartum individuals.
Eligibility Criteria
Inclusion Criteria for perinatal care setting team members: * Be employed by a participating perinatal care setting in a clinical role (including as an obstetrician-gynecologist, midwife, nurse practitioner, a nurse, a navigator, or administrative staff member who implemented the respective intervention during the study period). * Be 18 years of age or older * Provide verbal consent prior to the focus group or interview * Be proficient in English Inclusion Criteria for peer mentors: * Have completed PSI training to be a peer mentor * Be 18 years of age or older * Provide verbal consent prior to the focus group or interview * Be proficient in English Inclusion Criteria for perinatal individuals: * Have received perinatal care at a study partnering perinatal care setting during the study period * Be 18 years of age or older * Provide verbal consent prior to the focus group or interview * Be proficient in English or Spanish Exclusion Criteria: An individual who does not meet the inclusion criteria listed above will be excluded from participation in this study. There are no additional exclusion criteria.
Contact & Investigator
Nancy Byatt, DO, MS, MBA
PRINCIPAL INVESTIGATOR
UMass Chan Medical School and UMass Memorial Health
Frequently Asked Questions
Who can join the NCT06790641 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Perinatal Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06790641 currently recruiting?
Yes, NCT06790641 is actively recruiting participants. Contact the research team at Rebekah.Getman2@umassmed.edu for enrollment information.
Where is the NCT06790641 trial being conducted?
This trial is being conducted at Shrewsbury, United States.
Who is sponsoring the NCT06790641 clinical trial?
NCT06790641 is sponsored by University of Massachusetts, Worcester. The principal investigator is Nancy Byatt, DO, MS, MBA at UMass Chan Medical School and UMass Memorial Health. The trial plans to enroll 1,270 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.